Biotricity Stock Current Valuation

BTCY Stock  USD 1.48  0.12  8.82%   
Valuation analysis of Biotricity helps investors to measure Biotricity's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Multiple is likely to drop to -2.05 in 2024. Fundamental drivers impacting Biotricity's valuation include:
Price Book
33.0205
Enterprise Value
36.3 M
Enterprise Value Ebitda
(3.80)
Price Sales
1.199
Enterprise Value Revenue
3.1255
Undervalued
Today
1.48
Please note that Biotricity's price fluctuation is extremely dangerous at this time. Calculation of the real value of Biotricity is based on 3 months time horizon. Increasing Biotricity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Biotricity is useful when determining the fair value of the Biotricity stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Biotricity. Since Biotricity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotricity Stock. However, Biotricity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.48 Real  2.08 Target  4.0 Hype  1.32
The real value of Biotricity Stock, also known as its intrinsic value, is the underlying worth of Biotricity Company, which is reflected in its stock price. It is based on Biotricity's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Biotricity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotricity's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.08
Real Value
12.65
Upside
Estimating the potential upside or downside of Biotricity helps investors to forecast how Biotricity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotricity more accurately as focusing exclusively on Biotricity's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.39-0.36-0.39
Details
Hype
Prediction
LowEstimatedHigh
0.071.3211.89
Details
1 Analysts
Consensus
LowTarget PriceHigh
3.644.004.44
Details

Biotricity Current Valuation Analysis

Biotricity's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total15.4M19.5M22.5M23.6M
Total Assets16.7M6.5M7.5M7.9M

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Biotricity Current Valuation

    
  36.34 M  
Most of Biotricity's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotricity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biotricity Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Biotricity is extremely important. It helps to project a fair market value of Biotricity Stock properly, considering its historical fundamentals such as Current Valuation. Since Biotricity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biotricity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biotricity's interrelated accounts and indicators.
0.55-0.490.610.53-0.810.570.890.820.760.970.570.7-0.30.750.660.45-0.370.530.590.250.80.8-0.750.83-0.37-0.37
0.55-0.710.620.6-0.740.660.790.720.730.470.840.67-0.830.50.610.52-0.430.83-0.14-0.450.590.47-0.550.52-0.43-0.43
-0.49-0.71-0.67-0.970.85-0.97-0.75-0.84-0.93-0.31-0.94-0.690.38-0.68-0.69-0.950.66-0.950.370.65-0.82-0.810.84-0.80.660.66
0.610.62-0.670.65-0.880.760.770.890.750.50.810.89-0.490.70.810.6-0.490.73-0.07-0.360.650.62-0.650.62-0.49-0.49
0.530.6-0.970.65-0.830.980.750.850.950.330.90.63-0.210.660.690.99-0.790.91-0.29-0.560.850.89-0.930.85-0.79-0.79
-0.81-0.740.85-0.88-0.83-0.89-0.94-0.99-0.94-0.7-0.9-0.910.48-0.86-0.84-0.760.52-0.85-0.060.31-0.89-0.850.84-0.880.520.52
0.570.66-0.970.760.98-0.890.790.910.960.380.940.74-0.320.720.740.96-0.770.93-0.27-0.550.850.88-0.920.84-0.77-0.77
0.890.79-0.750.770.75-0.940.790.950.910.80.850.8-0.510.80.850.67-0.540.830.18-0.20.870.82-0.830.85-0.54-0.54
0.820.72-0.840.890.85-0.990.910.950.960.690.910.88-0.440.830.860.79-0.640.870.06-0.30.890.88-0.90.88-0.64-0.64
0.760.73-0.930.750.95-0.940.960.910.960.60.930.77-0.370.780.780.9-0.720.92-0.04-0.380.920.93-0.960.92-0.72-0.72
0.970.47-0.310.50.33-0.70.380.80.690.60.410.66-0.30.70.550.24-0.130.350.720.40.70.64-0.570.73-0.13-0.13
0.570.84-0.940.810.9-0.90.940.850.910.930.410.77-0.570.720.780.86-0.690.99-0.31-0.630.790.75-0.820.74-0.69-0.69
0.70.67-0.690.890.63-0.910.740.80.880.770.660.77-0.550.830.740.56-0.30.690.09-0.230.790.66-0.640.75-0.3-0.3
-0.3-0.830.38-0.49-0.210.48-0.32-0.51-0.44-0.37-0.3-0.57-0.55-0.36-0.47-0.110.08-0.520.110.33-0.22-0.070.13-0.140.080.08
0.750.5-0.680.70.66-0.860.720.80.830.780.70.720.83-0.360.760.6-0.30.670.16-0.150.860.74-0.70.83-0.3-0.3
0.660.61-0.690.810.69-0.840.740.850.860.780.550.780.74-0.470.760.62-0.520.75-0.05-0.370.70.66-0.690.67-0.52-0.52
0.450.52-0.950.60.99-0.760.960.670.790.90.240.860.56-0.110.60.62-0.790.88-0.36-0.590.810.86-0.90.81-0.79-0.79
-0.37-0.430.66-0.49-0.790.52-0.77-0.54-0.64-0.72-0.13-0.69-0.30.08-0.3-0.52-0.79-0.710.270.41-0.52-0.70.81-0.521.01.0
0.530.83-0.950.730.91-0.850.930.830.870.920.350.990.69-0.520.670.750.88-0.71-0.37-0.670.780.73-0.810.72-0.71-0.71
0.59-0.140.37-0.07-0.29-0.06-0.270.180.06-0.040.72-0.310.090.110.16-0.05-0.360.27-0.370.920.120.16-0.040.210.270.27
0.25-0.450.65-0.36-0.560.31-0.55-0.2-0.3-0.380.4-0.63-0.230.33-0.15-0.37-0.590.41-0.670.92-0.2-0.130.25-0.110.410.41
0.80.59-0.820.650.85-0.890.850.870.890.920.70.790.79-0.220.860.70.81-0.520.780.12-0.20.92-0.90.98-0.52-0.52
0.80.47-0.810.620.89-0.850.880.820.880.930.640.750.66-0.070.740.660.86-0.70.730.16-0.130.92-0.980.96-0.7-0.7
-0.75-0.550.84-0.65-0.930.84-0.92-0.83-0.9-0.96-0.57-0.82-0.640.13-0.7-0.69-0.90.81-0.81-0.040.25-0.9-0.98-0.920.810.81
0.830.52-0.80.620.85-0.880.840.850.880.920.730.740.75-0.140.830.670.81-0.520.720.21-0.110.980.96-0.92-0.52-0.52
-0.37-0.430.66-0.49-0.790.52-0.77-0.54-0.64-0.72-0.13-0.69-0.30.08-0.3-0.52-0.791.0-0.710.270.41-0.52-0.70.81-0.521.0
-0.37-0.430.66-0.49-0.790.52-0.77-0.54-0.64-0.72-0.13-0.69-0.30.08-0.3-0.52-0.791.0-0.710.270.41-0.52-0.70.81-0.521.0
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Biotricity has a Current Valuation of 36.34 M. This is 99.75% lower than that of the Health Care Equipment & Supplies sector and 99.71% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.78% higher than that of the company.

Biotricity Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotricity's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotricity could also be used in its relative valuation, which is a method of valuing Biotricity by comparing valuation metrics of similar companies.
Biotricity is currently under evaluation in current valuation category among related companies.

Biotricity Fundamentals

About Biotricity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biotricity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotricity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotricity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotricity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotricity's short interest history, or implied volatility extrapolated from Biotricity options trading.

Pair Trading with Biotricity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.

Moving against Biotricity Stock

  0.73MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.67MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.55TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Biotricity Piotroski F Score and Biotricity Altman Z Score analysis.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.